Active B12 Test Market Analysis 2019 Key News by Top Companies with Latest Technology, Developments, Revenue, Size and Industry Growth Insights to 2023

-

Vitamin B12 plays an important role to keep our body stay healthy. Our body is not capable to produce vitamin B12, thus, we have to get it from animal-based foods or supplements. As our body does not store vitamin B12, so we need to intake these animal-based foods or supplements regularly. Vitamin B12, also known as cobalamin, is a water-soluble vitamin that plays a key role in the functioning of the brain and nervous system and the formation of red blood cells. Rising prevalence of vitamin deficiency disease and neurological disorders increase the market of active B12 test globally. According United States Department of Agriculture Agricultural Research Service, the prevalence of vitamin deficiency is found to be high in America. Additionally, according to report published by Alzheimer's Disease International (ADI), in 2015, the prevalence of occurring dementia is more in middle-income countries in comparison to a developed nation.

Companies are showing much interest in the market of active B12 Test, as they feel there are huge opportunities and gaps between the market demand and supply of active B12 Test market. Thus, companies are showing more interest in research and development activities for introducing the best procedure that meets the requirement of the market. The development has been made by Axis-Shield Diagnostics Ltd. In Sep 2014, will develop the Active-B12 test for Siemens Healthcare allowing more laboratories worldwide to perform the test.


Global Key Players
·         Axis-Shield Diagnostics Ltd. (U.S.),
·         Abbott (U.S.),
·         Siemens Healthcare Private Limited (U.S.),
·         DiaSorin S.p.A. (Italy),
·         LifeSpan BioSciences, Inc. (U.S.),
·         Demeditec Diagnostics GmbH (Germany)

Global Active B12 Test Market - Regional Analysis

According to a report published by Alzheimer's Disease International (ADI), in 2015, around 46.8 million people globally have dementia and it is projected to be around 74.7 million in 2030 and 131.5 million in 2050. Also, according to a report published by WHO in 2017, around 50 million people are suffering from epilepsy globally.
The market of active B12 test is much higher in the Americas region. There are several factors for the tremendous growth of the active B12 test market in this region such as wider acceptance of the technology, Major players belong from this region. According to a report published by Alzheimer's Disease International (ADI), in 2015, around 4.8 million are suffering from dementia in North Americas.

Europe is also considered a huge market for active B12 test players, owing to the present of the huge patient population. Moreover, countries in this region have a well-established health care structure. The population within the reason are more aware of healthcare in comparison to another region like the Asia Pacific and The Middle East and Africa.

Browse Full Report @ https://www.marketresearchfuture.com/reports/active-b12-test-market-4199

The Asia Pacific and the Middle East and Africa region are considering the big opportunity for the market players owing to the presence of a huge patient population. Whereas country like India and china of the Asia Pacific region are considering the fastest-growing region. These countries are open to adopting new technology, and the best treatment option from developed countries in order to improve the quality of life for their public. In 2014, Japanese Pharmaceutical R&D expenditure was around ¥ 14.95 Billion. Japan is a well-developed country and has a well-established healthcare system and technology, whereas developing countries are still focusing on new drugs and technology which lead to an increase in the demand for various active B12 tests in the drug development and delivery process for the treatment.

Browse Other Healthcare Related Reports
Population Health Management Market Research Report- Global Forecast To 2023
Syringe and Needle Market Research Report - Global Forecast to 2027

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services

Contact:
https://www.marketresearchfuture.com/




Comments

Post a Comment

Popular posts from this blog

Insulin Delivery Devices Market Analysis Outlook 2025 By Top Manufactures Size, Trends, Demand and Growth Prospects 2020

-
  Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025 The Global  Insulin Delivery Devices Market  size is estimated to grow at a  CAGR of 7.85%  and expected to reach  USD 21,804  Million by 2025, says Market Research Future (MRFR). Insulin, a glucose directing hormone, assumes a fundamental job in the whole treatment of diabetes. Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin. Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively a...
Read more

Krabbe Disease Treatment Market Application,Trends, Growth Top Companies, Demand and Forecasts To 2022

-
Krabbe Disease Treatment Market Information, by Types of treatments (anticonvulsant medication, physical therapy, muscle relaxer drugs, Bone Marrow Transplantation) by end users (Hospitals and Clinics, Research Centers, laboratories) - Forecast to 2022 Krabbe disease is an incurable medical condition where the protective coating of nerve cells around the brain are destroyed which causing nerve damage. The global Krabbe disease treatment market can reach a significant valuation, exhibiting a steady CAGR over the forecast period of 2016 to 2022, as per a research report published by Market Research Future (MRFR). The market has been growing continuously on account of increasing incidence of Krabbe disease across the globe. Classification of Krabbe disease under orphan disease has propelled the growth of the market. Pharmaceutical companies receive incentives to develop medicine for rare disease along with reduced fees in protocol assistance and protection from competition after the m...
Read more

Animal Vaccines Market Analysis Worldwide 2019 -Global Trends, Size, Analysis, Emerging Factors, Competitive Landscape, Regional Analysis and Forecast to 2023

-
The Animal Vaccines Market Research Report – Global Forecast till 2023 provides detail information and strategies of top key players in the industry. The report also gives a broad study about different markets segments and regions. Animal Vaccines Market The Global Animal Vaccines Market is expected to grow at an approximate CAGR of 5.65% during forecast period, 2018–2023. Increasing participation of market players is the key factor driving the animal vaccines market. For instance, in 2015, Boehringer Ingelheim launched two new swine vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) i.e. Ingelvac PRRSFLEX EU for piglets and ReproCyc PRRS EU for breeding gilts. Segmentation The Global Animal Vaccines Market, by type is segmented into static porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others.   The livestock vaccine is further segmented into bovine vaccines, and small rumina...
Read more